CD34 and systemic sclerosis: Notably, using spatial proteomics, a very recent study by Rius Rigau et al. [15] confirmed the presence of a CD34+/α-SMA+/CD31+ EC subpopulation that was increased in the skin of SSc patients and expressed high levels of different transcription factors known to promote EndoMT.